Literature DB >> 14720534

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.

Carlo Patrono1, Fedor Bachmann, Colin Baigent, Christopher Bode, Raffaele De Caterina, Bernard Charbonnier, Desmond Fitzgerald, Jack Hirsh, Steen Husted, Jan Kvasnicka, Gilles Montalescot, Luis Alberto García Rodríguez, Freek Verheugt, Jozef Vermylen, Lars Wallentin, Silvia G Priori, Maria Angeles Alonso Garcia, Jean Jacques Blanc, Andrzej Budaj, Martin Cowie, Veronica Dean, Jaap Deckers, Enrique Fernández Burgos, John Lekakis, Bertil Lindahl, Gianfranco Mazzotta, João Morais, Ali Oto, Otto A Smiseth, João Morais, Jaap Deckers, Rafael Ferreira, Gianfranco Mazzotta, Philippe Gabriel Steg, Frederico Teixeira, Robert Wilcox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720534     DOI: 10.1016/j.ehj.2003.10.013

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  53 in total

1.  Understanding the delicate balance between bleeding and thrombosis: can we use it to our advantage?

Authors:  Filip De Somer
Journal:  J Extra Corpor Technol       Date:  2012-03

2.  Upper Gastrointestinal Symptoms Experienced by Users of Low-Dose Aspirin (Acetylsalicylic Acid) [75-325 mg/day] for Primary and Secondary Coronary Artery Disease Prevention: Perspectives from Patient Focus Groups.

Authors:  Mary Kay Margolis; Katarina Halling; Elisabeth Sörstadius; Jørgen Næsdal; Stephanie Manson; Karin Coyne
Journal:  Patient       Date:  2009-06-01       Impact factor: 3.883

3.  Does low-dose ASA help prevent cardiovascular events in women?

Authors:  Abdullah Alkhenizan; W Farooq
Journal:  Can Fam Physician       Date:  2006-03       Impact factor: 3.275

Review 4.  Assessing the current role of platelet function testing.

Authors:  Eugene Braunwald; Dominick Angiolillo; Eric Bates; Peter B Berger; Deepak Bhatt; Christopher P Cannon; Mark I Furman; Paul Gurbel; Alan D Michelson; Eric Peterson; Stephen Wiviott
Journal:  Clin Cardiol       Date:  2008-03       Impact factor: 2.882

5.  Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.

Authors:  Szymon Olędzki; Zdzisława Kornacewicz-Jach; Krzysztof Safranow; Radosław Kiedrowicz; Barbara Gawrońska-Szklarz; Maria Jastrzębska; Jarosław Gorący
Journal:  Eur J Clin Pharmacol       Date:  2017-06-06       Impact factor: 2.953

6.  Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.

Authors:  Min Jun; Jicheng Lv; Vlado Perkovic; Meg J Jardine
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

Review 7.  P2Y12 receptor: platelet thrombus formation and medical interventions.

Authors:  Fatemeh Moheimani; Denise E Jackson
Journal:  Int J Hematol       Date:  2012-10-01       Impact factor: 2.490

8.  Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study.

Authors:  Rikke Sørensen; G H Gislason; E L Fosbøl; S Rasmussen; L Køber; J K Madsen; C Torp-Pedersen; S Z Abildstrom
Journal:  Br J Clin Pharmacol       Date:  2008-09-23       Impact factor: 4.335

9.  Perioperative management of antiplatelet-drugs in cardiac surgery.

Authors:  Raquel Ferrandis; Juan V Llau; Ana Mugarra
Journal:  Curr Cardiol Rev       Date:  2009-05

10.  Clinical outcomes of various continued antiplatelet therapies in patients who were administered DAPT following the implantation of drug-eluting stents and developed gastrointestinal hemorrhage.

Authors:  Yujie Guo; Jinru Wei
Journal:  Exp Ther Med       Date:  2016-05-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.